Work

Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells

Year: 2014

Type: article

Source: Oncogene

DOI: 10.1038/onc.2014.161

Authors: J Wang, O Mikse, R G Liao, Y Li, L Tan, P A Janne, N S Gray, K-k Wong, P S Hammerman

Institutions: Shanghai Medical College of Fudan University, Fudan University, Dana-Farber Cancer Institute, Broad Institute, Massachusetts Institute of Technology, Harvard University

Language: English

Topic: Fibroblast Growth Factor Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: V Foundation for Cancer Research, Ariad Pharmaceuticals, National Natural Science Foundation of China, China Scholarship Council, National Cancer Institute

Awards: G1282312431, Genomic Discovery and Targeted Therapeutics in Squamous Cell Lung Cancer, Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma, G7949798269

OpenAlex ID: W2055560819

FWCI: 2.312

Cites: 46

Cited by: 72

Related to: 10